ALISSA Bead Matrix for Attomolar Botulinum Neurotoxin Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting botulinum neurotoxins (BoNTs) in complex samples are not sensitive enough, as the 'gold standard' mouse toxicity assay can only detect as little as 10 pg BoNT, while BoNT can be lethal at systemic doses as low as 1-2 ng/Kg body weight, posing a significant analytical challenge for early detection and diagnosis.
Innovation Solution
The development of a method called Assay with a Large Immuno-sorbent Surface Area (ALISSA) that uses specific affinity enrichment of BoNT onto a bead matrix with immobilized antibodies, followed by fluorometric or luminescent readouts, allowing for detection of as little as 0.5 femtograms per mL sample, thereby enhancing sensitivity and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If mouse toxicity assay is used for BoNT detection, then detection capability is achieved, but sensitivity is insufficient (can only detect 10 pg BoNT)
Solution Approach 1:
The detection system is segmented into multiple functional components: bead-based immunoaffinity capture matrix for enrichment, fluorogenic substrate for signal generation, and readout system for detection. This segmentation allows each component to be optimized independently, achieving both high sensitivity and reliable detection capability.
Solution Approach 2:
A bead-based immunoaffinity capture matrix serves as an intermediary between the sample and detection system. The matrix concentrates BoNT from complex samples through specific antibody binding, then transfers the enriched toxin to the fluorogenic substrate for signal generation. This intermediary step enables detection at attomolar levels while maintaining detection reliability.
2Measurement precision
If affinity enrichment onto bead matrix is implemented, then sensitivity increases to attomolar levels, but device complexity increases
Solution Approach 1:
The bead-based immunoaffinity capture matrix performs multiple functions: it enriches BoNT from complex samples, concentrates the toxin for detection, and serves as a platform for controlled reaction with fluorogenic substrate. This multi-functionality reduces the need for separate enrichment and detection devices, managing complexity while achieving attomolar sensitivity.
Solution Approach 2:
The assay utilizes parameter changes in the form of fluorogenic substrate conversion. The substrate remains non-fluorescent until cleaved by BoNT, at which point it generates a fluorescent signal. This parameter change provides a simple, sensitive readout mechanism that does not require complex instrumentation, balancing sensitivity with manageable device complexity.
3Measurement precision
If conventional ELISA is used for BoNT detection, then detection is achieved, but sensitivity is insufficient (160,000-fold less sensitive than ALISSA)
Solution Approach 1:
The assay replaces the enzymatic amplification system of ELISA with a direct fluorogenic cleavage system. BoNT directly cleaves the fluorogenic substrate to generate signal, eliminating the need for secondary antibodies and enzymatic amplification steps. This substitution achieves 160,000-fold higher sensitivity while reducing assay steps and turnaround time.
Solution Approach 2:
The fluorogenic substrate remains in a non-fluorescent state until BoNT cleaves it, at which point fluorescence continuously increases as more substrate is converted. This continuous signal generation provides real-time detection without requiring multiple washing or incubation steps, improving both sensitivity and productivity compared to conventional ELISA.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
ALISSA achieves a sensitivity 32,000-fold greater than the mouse toxicity assay and 160,000-fold greater than ELISA, with a significantly faster turnaround time, enabling the detection of BoNT at attomolar levels, improving diagnostic capabilities and biodefense applications.
Implementation Method 1
specific affinity enrichment of a target toxin or target enzyme onto a solid support
Implementation Method 2
solid support is a bead matrix that contains immobilized, anti-enzyme-specific antibodies and/or anti-toxin-specific antibodies
Implementation Method 3
fluorometric readout is based on specific cleavage of a fluorogenic substrate
Implementation Method 4
BoNT-specific cleavage of a fluorogenic BoNT substrate
Implementation Method 5
luminescent based readout assays are provided for detection of BoNT. The methods include use of bioluminescent BoNT/A substrates including genetically engineered variants of recombinant luciferase proteins
Data Source
AI summary
Provided herein is a large immuno-sorbent surface area assay (ALISSA) for rapid and sensitive detection of toxin or enzyme activity. This assay is designed to capture a low number of toxin or enzyme molecules and to measure their intrinsic protease activity via conversion of a fluorogenic or luminescent substrate. The ALISSA is significantly faster and more sensitive than methods routinely utilized in the art. This assay is applicable for use for detection of a variety of toxins or enzymes having proteolytic activity, such as botulinum neurotoxin, bacillus anthracis lethal factor, human chitinases, and aspergillus fumigatus proteases. Also provided are methods for constructing and identifying novel luminescent or fluorescent substrates suitable for use with the ALISSA method.